
The risk environment surrounding gender-affirming care (GAC) is shifting more rapidly in 2026 than at any point in the past decade. Federal policy reversals, conflicting state laws and evolving insurer behavior are reshaping underwriting norms and compliance exposure for healthcare organizations. While public-sector programs have historically been indicators of where commercial carriers may trend, this year’s regulatory changes signal a decisive shift in how GAC will be financed, scrutinized and litigated across the U.S.
Healthcare organizations, especially those offering care to minors, now face heightened uncertainty in rate-setting, coverage terms, documentation standards and legal vulnerability. Proactive preparation is now a strategic imperative.
Why gender-affirming care policy changes matter in 2026
Recent federal actions have materially changed the financial and regulatory landscape for gender-affirming care.
The Office of Personnel Management (OPM) eliminates GAC coverage in Federal Employees Health Benefits (FEHB) plans – effective 2026
OPM has removed all coverage for gender-affirming treatments, including hormonal and surgical interventions for all ages under the FEHB program. This represents one of the most sweeping federal reversals on GAC coverage to date and is viewed by carriers as a directional signal for the commercial market.
CMS authorizes exclusion of GAC from essential health benefits (EHB) – 2026
CMS has finalized rules allowing ACA marketplace insurers to exclude GAC from EHBs. Though not a mandate, this policy authorizes carriers to narrow coverage, implement exclusions, or shift costs to states and individuals.
State laws diverge, creating compliance conflicts
States are increasingly polarized, some restricting or banning GAC for minors, while others explicitly protect access. These laws increasingly conflict with federal nondiscrimination statutes such as ACA §1557 and Title VII, creating direct compliance tensions for providers operating across state lines.
Impact: Collectively, these shifts heighten uncertainty for insurers, resulting in increased scrutiny, pricing adjustments and early movement toward coverage limitations.
How gender-affirming care policy shifts impact healthcare organizations
Underwriting and coverage behavior
Underwriters are now more frequently evaluating:
- Whether an organization provides GAC, particularly to minors
- Behavioral health evaluation and consent standards
- Clinical oversight of hormone and surgical pathways
- Litigation exposure tied to nondiscrimination laws
- Documentation practices demonstrating alignment with recognized standards of care
As insurer appetite changes, organizations offering pediatric GAC may experience:
- Rate increases tied to perceived litigation and regulatory risk
- Coverage limitations or sublimits
- Requests for detailed program documentation
- Potential exclusions, mirroring early precedents from public sector plans
The legal and compliance environment
Healthcare entities now operate within a patchwork of conflicting mandates.
State restrictions vs. federal nondiscrimination protections
Some states prohibit or limit GAC for minors, yet federal civil rights interpretations may categorize GAC denial as sex discrimination under ACA §1557 or Title VII. This conflict exposes organizations to:
- Regulatory audits
- Patient complaints
- Civil rights litigation
Regulatory instability at the federal level
Executive-driven policy shifts have changed agency enforcement priorities, coverage norms and interpretive guidance. With CMS and OPM altering national coverage rules, courts and agencies are already fielding legal challenges from advocacy groups and impacted individuals.
Bottom line: Providers must expect increased scrutiny of access policies, documentation, communication practices and nondiscrimination compliance, especially in pediatric settings.
Action steps healthcare organizations should take now
- Maintain standardized protocols for behavioral health evaluations, hormone therapy and surgical eligibility
- Ensure informed consent processes, especially for minors are consistent, detailed and aligned with widely recognized standards of care
- Document clinical rationales thoroughly and consistently
- Map state laws and federal requirements to identify areas of potential conflict
- Establish a regulatory monitoring team (compliance, legal, clinical leadership) to track rapid federal actions, injunctions and appeals
- Build an internal rapid‑response process for policy updates as regulations evolve
- Engage legal counsel to evaluate civil rights exposure under ACA §1557 and Title VII
- Develop a concise, insurer‑ready program summary outlining services, age ranges, clinical oversight and safety processes
- Track outcomes, adverse events, committee minutes and quality metrics
- Demonstrate proactive risk governance
- Weigh the operational, reputational and financial impact of providing GAC to minors
- Consider scenario planning for litigation, audits and coverage changes
- Standardize internal and external messaging rooted in clinical standards and regulatory obligations
- Equip leaders, clinicians and patient-facing staff with neutral talking points to reduce inconsistency and mitigate reputational risk
Key takeaways and closing comments
As the regulatory environment continues to shift, the implications for healthcare organizations offering GAC are both immediate and profound. Federal policy changes taking effect in 2026, most notably FEHB’s categorical exclusions and the new ACA EHB flexibility, are already influencing insurer behavior and will likely set the tone for future commercial coverage standards.
At the same time, persistent conflicts between rapidly evolving state laws and unsettled federal civil rights protections are fueling compliance ambiguity and elevating the risk of litigation across multiple jurisdictions. Against this backdrop, organizations delivering gender-affirming care, particularly pediatric services, should anticipate intensified underwriting scrutiny, rising premiums, new documentation expectations and potential restrictions in coverage. Navigating this environment requires disciplined governance, rigorous legal review and strengthened documentation protocols.
By proactively reinforcing these foundations, healthcare organizations can better position themselves to manage uncertainty, demonstrate credibility to regulators and insurers and continue delivering safe, compliant, patient‑centered care amid a highly dynamic policy landscape.
Disclaimer
WTW hopes you found the general information provided here informative and helpful. The information contained herein is not intended to constitute legal or other professional advice and should not be relied upon in lieu of consultation with your own legal advisors. In the event you would like more information regarding your insurance coverage, please do not hesitate to reach out to us. In North America, WTW offers insurance products through licensed entities, including Willis Towers Watson Northeast, Inc. (in the United States) and Willis Canada Inc. (in Canada).







